Pliant Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Pliant Therapeutics is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is €-0.73. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	$ 248.00K	$ 1.33M	$ 1.97M
Gross Profit	-	-	$ 248.00K	$ 1.33M	$ 1.97M
EBIT	$ -47.04M	$ -47.69M	$ -47.33M	$ -41.47M	$ -37.40M
EBITDA	$ -40.85M	-	$ -50.23M	$ -42.94M	$ -38.21M
Net Income Common Stockholders	$ -41.11M	$ -41.49M	$ -41.19M	$ -36.92M	$ -35.06M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 494.25M	$ 523.61M	$ 555.16M	$ 577.31M	$ 331.19M
Total Assets	$ 512.15M	$ 540.46M	$ 574.89M	$ 593.68M	$ 350.61M
Total Debt	$ 11.37M	$ 12.08M	$ 14.54M	$ 15.19M	$ 15.81M
Net Debt	$ -482.87M	$ -511.53M	$ -540.62M	$ -562.13M	$ -315.37M
Total Liabilities	$ 38.58M	$ 37.42M	$ 41.83M	$ 35.96M	$ 37.27M
Stockholders Equity	$ 473.58M	$ 503.05M	$ 533.07M	$ 561.92M	$ 313.34M
Cash Flow	-
Free Cash Flow	$ -25.16M	-	$ -25.44M	$ -30.39M	$ -31.41M
Operating Cash Flow	$ -25.10M	$ -36.22M	$ -24.84M	$ -30.23M	$ -31.24M
Investing Cash Flow	$ 31.92M	$ 38.25M	$ -22.98M	$ -174.21M	$ 20.02M
Financing Cash Flow	$ 219.00K	$ 699.00K	$ 161.00K	$ 273.33M	$ 284.00K

Currency in USD

Pliant Therapeutics Earnings and Revenue History

Income Statement >

Pliant Therapeutics Debt to Assets

Balance Sheet >

Pliant Therapeutics Cash Flow

Cash Flow >

Pliant Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing